NCT02055170View on ClinicalTrials.gov

Neoadjuvant Finasteride for Patients With Non-small Cell Lung Cancer

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

March 27, 2018

Study Completion Date

March 27, 2018

Conditions
Non-small Cell Lung Cancer
Interventions
DRUG

finasteride 5mg oral daily

Trial Locations (1)

R3A1R9

Health Sciences Centre, Winnipeg

Sponsors
All Listed Sponsors
lead

CancerCare Manitoba

OTHER